Patents by Inventor Peipei WEI

Peipei WEI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-EGFR NANOBODY AND USE THEREOF
    Publication number: 20240101686
    Abstract: An EGFR nanobody, and a preparation method therefor and the use thereof. The EGFR nanobody has high affinity for a wild-type EGRF protein, and also recognizes the EGRFvIII protein.
    Type: Application
    Filed: December 8, 2021
    Publication date: March 28, 2024
    Inventors: Peipei Wei, Cuiqing Yang, Zhuoxiao Cao, Renhong Tang, Jinsheng Ren
  • Anti-human LAG-3 monoclonal antibody and use thereof
    Patent number: 11685778
    Abstract: Disclosed in the present invention are an antibody targeting LAG-3, a preparation method therefor and the use thereof. In particular, disclosed in the present invention is a novel monoclonal antibody targeting LAG-3. Also disclosed in the present invention is a method for the preparation of the monoclonal antibody. The monoclonal antibody of the present invention is capable of binding LAG-3 antigens with high specificity, and has very high affinity and significant activities such as anti-tumor activity.
    Type: Grant
    Filed: April 2, 2019
    Date of Patent: June 27, 2023
    Assignee: JIANGSU HUAIYU PHARMACEUTICAL CO., LTD.
    Inventors: Ningning Song, Qing Duan, Xiaohui Shao, Peng Wang, Xiaojiao Bian, Qian Wang, Peipei Wei, Yajun Huang, Jian Wu, Meiling Wang, Yuandong Wang, Lina Xu, Tatchi Teddy Yang, Lile Liu
  • ANTI-HUMAN TIM-3 MONOCLONAL ANTIBODY AND APPLICATION THEREOF
    Publication number: 20220033501
    Abstract: Provided are a high-affinity full human monoclonal antibody highly specifically targeting to TIM-3 and a preparation method therefor. The monoclonal antibody has a remarkable antitumor activity, and can be used for preparing a related diagnostic reagent or a pharmaceutical composition preventing or treating diseases related to TIM-3 dysfunction.
    Type: Application
    Filed: December 2, 2019
    Publication date: February 3, 2022
    Inventors: Ningning SONG, Qing DUAN, Lile LIU, Tatchi Teddy YANG, Lina XU, Hu LIU, Peipei WEI, Qian WANG, Yuangdong WANG, Xiaohui SHAO, Shaoping HU, Yu ZHANG, Jian WU, Meilling WANG, Dongxu WANG, Chaohui DAI, Mengying WANG
  • ANTI-HUMAN LAG-3 MONOCLONAL ANTIBODY AND USE THEREOF
    Publication number: 20210155689
    Abstract: Disclosed in the present invention are an antibody targeting LAG-3, a preparation method therefor and the use thereof. In particular, disclosed in the present invention is a novel monoclonal antibody targeting LAG-3. Also disclosed in the present invention is a method for the preparation of the monoclonal antibody. The monoclonal antibody of the present invention is capable of binding LAG-3 antigens with high specificity, and has very high affinity and significant activities such as anti-tumor activity.
    Type: Application
    Filed: April 2, 2019
    Publication date: May 27, 2021
    Applicants: SHANGHAI PHARMAEXPLORER CO., LTD., PHARMAEXPLORER LIMITED
    Inventors: Ningning SONG, Qing DUAN, Xiaohui SHAO, Peng WANG, Xiaojiao BIAN, Qian WANG, Peipei WEI, Yajun HUANG, Jian WU, Meiling WANG, Yuandong WANG, Lina XU, Tatchi Teddy YANG, Lile LIU